PDF(Pubmed)
Abstract：
Immunotherapy and the implementation of more aggressive treatment schemes for locally advanced hepatocellular carcinomas have expanded the boundaries of curative options. Because of these advancements, patients who were once considered beyond the aim of a cure are now eligible for liver transplantation and resection.
摘要：
免疫治疗和对局部晚期肝细胞癌实施更积极的治疗方案扩大了治疗选择的范围。由于这些进步，曾经被认为超出治愈目标的患者现在可以接受肝移植和切除术.
